Akçetin Z, Pregla R, Busch A, Kessler G, Heynemann H, Holtz J, Brömme H
Department of Urology, Friedrich Alexander University, Erlangen, Germany.
Urol Int. 2000;65(1):32-9. doi: 10.1159/000064831.
Because of the continuing shortage of donor organs, 'marginal kidneys' are increasingly being used. The purpose of our experiments was to characterize the extent of lipid peroxidation after ischemia-reperfusion (IR) injury in rat kidney, to analyze the expressional regulation of the heat-shock response and now to discuss the clinical application of these results. After ischemia, xanthine oxidase (XO) is thought to be the main oxygen radical-generating system and malondialdehyde (MDA) is considered to be a marker of LPO. In young rats (10 weeks) a unilateral warm ischemia of 40 and 60 min duration with subsequent reperfusion up to 1 h was conducted. Beside the 'footprints' of oxidative stress, the cytosolic antioxidative capacity, expressed as superoxide anion (SOA) scavenging capacity, was investigated. There was only a moderate and transient increase of renal MDA 5 and 10 min after the onset of reoxygenation (133.57/70.67 and 97.84/91.57 vs. 49.47 nmol/g wet weight (ww) in preischemic controls). ATP breakdown (to 83/65 from 2,947 nmol/g ww) with consecutive accumulation of hypoxanthine (up to 1,105 nmol/g ww) at the end of the ischemic period and the subsequent rapid decline of hypoxanthine by XO during reperfusion were used for an assessment of the SOA-generating capacity of these kidneys. Only 1/25-1/50 of the kidney cytosol was able to scavenge the whole amount of SOA generated by the total XO activity of rat kidney. Thus, it could be analytically and stoichiometrically shown that after IR there is only a moderate oxidative stress in kidneys of young rats; this is due to their high SOA-scavenging capacity compared to their SOA-generating ability. We investigated the time course of HSP70-1 and -2 mRNA expression and its relation to cellular ATP levels in renal cortex after different periods of unilateral warm renal ischemia (10-60 min) and reperfusion (up to 60 min) in 10-week-old male Wistar rats, since IR is known to cause induction of both genes. Immediately after ischemia there was a significant induction of both HSP70i genes. While HSP70-1 expression constantly increased (up to 4-fold) during reperfusion, even to a higher extent with prolongation of ischemia, HSP70-2 mRNA - generally being expressed on a far lower level than HSP70-1 mRNA - was strongly induced (3-fold) during reperfusion only after brief periods (10 min) of ischemia. Cellular ATP levels rapidly dropped down to 5% with ischemia and the pattern of recovery during reperfusion significantly depended on the duration of the ischemic period thus showing a good relation to the heat-shock (protein) gene expression. We conclude that the HSP70-2 is the more sensitive gene with a lower threshold activation by mild injury, while the HSP70-1 gene mediates the big response of HSP induction after severe injury. Thus, the measurement of the cytosolic antioxidative capacity and the differential expression of HSP70-1 and -2 mRNA could be promising clinical tools to assess the donor viability.
由于供体器官持续短缺,“边缘肾脏”正越来越多地被使用。我们实验的目的是确定大鼠肾脏缺血再灌注(IR)损伤后脂质过氧化的程度,分析热休克反应的表达调控,并探讨这些结果的临床应用。缺血后,黄嘌呤氧化酶(XO)被认为是主要的氧自由基生成系统,丙二醛(MDA)被视为脂质过氧化的标志物。对年轻大鼠(10周龄)进行了持续40和60分钟的单侧热缺血,随后再灌注1小时。除了氧化应激的“印记”外,还研究了以超氧阴离子(SOA)清除能力表示的胞质抗氧化能力。再氧合开始后5分钟和10分钟时,肾脏MDA仅出现中度和短暂升高(分别为133.57/70.67和97.84/91.57,而缺血前对照组为49.47 nmol/g湿重(ww))。缺血末期ATP分解(从2947 nmol/g ww降至83/65),同时次黄嘌呤持续积累(高达1105 nmol/g ww),再灌注期间XO使次黄嘌呤迅速下降,以此评估这些肾脏的SOA生成能力。仅1/25 - 1/50的肾脏胞质能够清除大鼠肾脏总XO活性产生的全部SOA。因此,从分析和化学计量学角度可以表明IR后年轻大鼠肾脏仅存在中度氧化应激;这是由于与SOA生成能力相比,它们具有较高的SOA清除能力。我们研究了10周龄雄性Wistar大鼠单侧热肾缺血不同时间段(10 - 60分钟)及再灌注(长达60分钟)后,肾皮质中HSP70 - 1和 - 2 mRNA表达的时间进程及其与细胞ATP水平的关系,因为已知IR会诱导这两个基因。缺血后立即出现这两个HSP70i基因的显著诱导。虽然HSP70 - 1表达在再灌注期间持续增加(高达4倍),随着缺血时间延长增加幅度更大,但HSP70 - 2 mRNA(其表达水平通常远低于HSP70 - 1 mRNA)仅在短暂缺血(10分钟)后的再灌注期间被强烈诱导(3倍)。缺血时细胞ATP水平迅速降至5%,再灌注期间的恢复模式显著取决于缺血时间,因此与热休克(蛋白)基因表达有良好关系。我们得出结论,HSP70 - 2是更敏感的基因,轻度损伤即可使其激活阈值降低,而HSP70 - 1基因介导严重损伤后HSP诱导的强烈反应。因此,测定胞质抗氧化能力以及HSP70 - 1和 - 2 mRNA的差异表达可能是评估供体活力的有前景的临床工具。